Tenofovir Disoproxil Fumarate (TDF)) HIV Paediatric Educational Brochure
Brochure providing important advice on the management of potential renal and bone effects of TDF in children and adolescent patients with HIV-1 aged 2 to <18 years, and on the dosing recommendations for TDF in this population.